+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Adenosine triphosphate and adenosine: perspectives in the acute management of paroxysmal supraventricular tachycardia



Adenosine triphosphate and adenosine: perspectives in the acute management of paroxysmal supraventricular tachycardia



Clinical Cardiology 8(9): 460-464



Adenosine triphosphate (ATP) and adenosine exert strong and transient depressant effects on the sinoatrial and atrioventricular (AV) nodes of the human heart. The AV nodal effects of these drugs explain their high efficacy in either terminating AV re-entrant supraventricular tachycardia or in slowing ventricular rate during atrial tachyarrhythmias. Their very short half-life enables repeated administration of increased doses without reaching toxic effects and explains the transient character of their frequent but benign side effects. These agents represent a good alternative to verapamil in the acute management of paroxysmal supraventricular tachycardia both in infants and adults.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 039187295

Download citation: RISBibTeXText

PMID: 4042450

DOI: 10.1002/clc.4960080903


Related references

Acute management of paroxysmal supraventricular tachycardia: verapamil, adenosine triphosphate or adenosine?. American Journal of Cardiology 54(1): 225-227, 1984

Acute management of paroxysmal supraventricular tachycardia verapamil, adenosine triphosphate or adenosine?: Belhassen B, Pelleg A Am J Cardiol 54:225227 Jul 1984. Annals of Emergency Medicine 13(11): 1073-1074, 1984

What is the drug of choice for the acute termination of paroxysmal supraventricular tachycardia: verapamil, adenosine triphosphate, or adenosine?. Pacing and Clinical Electrophysiology 16(8): 1735-1741, 1993

Adenosine triphosphate (ATP) in the management of paroxysmal supraventricular tachycardia: experience in the neonatal period. Revista Espanola de Cardiologia 48(4): 260-265, 1995

The use of adenosine triphosphate in supraventricular paroxysmal tachycardia. Arquivos Brasileiros de Cardiologia 66(2): 87, 1996

Treatment of paroxysmal supraventricular tachycardia with adenosine-5'-triphosphate. Zhonghua Nei Ke Za Zhi 24(5): 276-9, 318, 1985

Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia. Revista Espanola de Cardiologia 40(6): 431-433, 1987

Clinical experiences with adenosine triphosphate for acute management of supraventricular tachycardia. Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association 86(2): 98-103, 1987

Adenosine triphosphate in the diagnosis and treatment of paroxysmal supraventricular tachycardia. Polski Tygodnik Lekarski 42(23): 717-720, 1987

Treatment of paroxysmal supraventricular tachycardia with intravenous injection of adenosine triphosphate. British Heart Journal 55(3): 291-294, 1986

Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia: a comparison with verapamil. Revista Espanola de Cardiologia 48(1): 55-58, 1995

Adenosine triphosphate in the treatment of supraventricular paroxysmal tachycardia: comparison with verapamil. Revista Espanola de Cardiologia 48(7): 499-500, 1995

Efficacy and safety of adenosine triphosphate in the control of supraventricular paroxysmal tachycardia. Revista Portuguesa de Cardiologia 13(3): 197-202, 191, 1994

Effects of adenosine 5' triphosphate atp with premedication of dipyridamole on paroxysmal supraventricular tachycardia psvt. Japanese Circulation Journal 52(9): 1040, 1988

Comparative study between verapamil and adenosine triphosphate in the treatment of paroxysmal supraventricular tachycardia. Arquivos Brasileiros de Cardiologia 66(2): 55-57, 1996